Edit |   |
---|---|
Product Name | Recombinant human LINGO-1 protein |
Description | Domain: 241-337aa. Recombinant human LINGO1 protein, was expressed in E. coli. MW: 15.1 kDa (133aa). Purity > 90% by SDS-PAGE. Lingo1 also known as Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein1. LINGO-1 is primarily expressed in neuronal tissue, and most abundantly in cortex. It has been implicated in the inhibition of axon regeneration through a ternary complex formed with NgR1 (ligand-binding subunit) and p75 (signal transducing subunit). The inhibitory action is achieved through RhoA-GTP upregulation in response to the presence of MOG, MAG or Nogo-66 in the central nervous system. LINGO-1 also inhibits oligodendrocyte precursor differentiation and myelination, by a mechanism that also involves activation of RhoA, but which apparently does not require 75 or NgR1 |
Size | 20ug, 100ug, 500ug |
Concentration | 1mg/ml (determined by Bradford assay) |
Applications | SDS-PAGE,Denatured |
Other Names | Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein1, LERN1, LRRN6A, uNQ201 |
Gene, Accession, CAS # | NCBI: NP_116197, UniProt: Q96FE5 |
Catalog # | ATGP3011 |
Price | $80, $240, $720 |
Order / More Info | Recombinant human LINGO-1 protein from NKMAX Co. Ltd. |
Product Specific References | n/a |